Markets › United States › NAS › ADPT

Adaptive Biotechnologies Corp

NAS:ADPTHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$24.42+1.96%At closeAt close · Wed 21 Oct · ≈ AED 89.68 · Market cap $3.9B · Next earnings Wed 4 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	77.1%	68.1%	68.7%	55.6%	59.7%	74.2%	—	—
Operating margin	−155.3%	−135.4%	−108.0%	−133.3%	−90.8%	−20.6%	−20.6%	+0.0 pts
Net margin	−148.6%	−134.3%	−108.0%	−132.3%	−89.1%	−21.5%	−21.5%	+0.0 pts
EBITDA margin	−146.7%	−125.3%	−94.6%	−111.2%	−71.9%	−10.8%	—	—
Return on equity	−19.7%	−34.3%	−43.1%	−73.0%	−78.7%	−27.2%	−26.4%	+0.8 pts
Return on assets	−13.1%	−22.4%	−23.4%	−34.1%	−29.6%	−11.6%	−11.6%	+0.0 pts
Return on capital employed	−15.1%	−25.8%	−26.8%	−39.6%	−36.8%	−13.5%	—	—
Debt / equity	0.1×	0.2×	0.2×	0.3×	0.4×	1.3×	1.2×	−2.8%
Debt / assets	9.7%	12.1%	12.6%	14.9%	16.6%	54.7%	—	—
Interest coverage	0.0×	0.0×	−47.2×	−16.5×	−14.0×	−4.8×	—	—
Current ratio	6.9×	3.5×	5.1×	4.7×	2.9×	3.3×	3.3×	+0.0%
Quick ratio	6.8×	3.4×	5.0×	4.5×	2.8×	3.2×	—	—
Cash ratio	1.2×	1.2×	0.8×	0.7×	0.5×	0.8×	0.8×	+0.0%
Asset turnover	0.1×	0.2×	0.2×	0.3×	0.3×	0.5×	—	—
Inventory turnover	1.6×	2.6×	4.0×	5.2×	8.5×	7.3×	—	—
Receivables turnover	9.8×	8.9×	4.6×	4.5×	4.3×	5.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—